Novel therapeutics for dry eye disease

Duoduo Wua Department of Ophthalmology, National University Health System, Singapore, SingaporeView further author information

Louis Tongb Singapore Eye Research Institute, Singapore, Singapore;c Duke-NUS Graduate Medical School, Singapore, Singapore;d Singapore National Eye Centre, Singapore, SingaporeView further author information

Arun Prasathe Singapore Cord Blood Bank, Singapore, SingaporeView further author information

Blanche Xiao Hong Lima Department of Ophthalmology, National University Health System, Singapore, Singapore;f Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeView further author information

Dawn Ka-Ann Lima Department of Ophthalmology, National University Health System, Singapore, Singapore;f Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeView further author information

Chris Hong Long Lima Department of Ophthalmology, National University Health System, Singapore, Singapore;b Singapore Eye Research Institute, Singapore, Singapore;f Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;g School of Optometry and Vision Science, University of New South Wales, Sydney, AustraliaCorrespondence[email protected]
View further author information

References

Sheppard J, Shen Lee B, Periman LM. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med. 2023;55(1):241–252.
PubMed Web of Science ®Google Scholar
Nakamura M, Imanaka T, Sakamoto A. Diquafosol ophthalmic solution for dry eye treatment. Adv Ther. 2012;29(7):579–589.
PubMed Web of Science ®Google Scholar
Zhao X, Xia S, Chen Y. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: a meta-analysis of randomized controlled trials. Medicine. 2017;96(39):e8174.
PubMed Web of Science ®Google Scholar
Metheetrairut C, Ngowyutagon P, Tunganuntarat A, et al. Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease. Sci Rep. 2022;12(1):8906.
PubMed Web of Science ®Google Scholar
Belderbos ME, Levy O, Meyaard L, et al. Plasma-mediated immune suppression: a neonatal perspective. Pediatr Allergy Immunol off Publ Eur Soc Pediatr Allergy Immunol. 2013;24(2):102–113.
PubMed Web of Science ®Google Scholar

Novel therapeutics for dry eye disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Novel therapeutics for dry eye disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date